Clinical Trial Update: Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating bavituximab with sorafenib in advanced hepatocellular carcinoma (liver cancer) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• Bavituximab (bavituximab)
• Sorafenib (Sorafenib)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-12